|
1
|
Omar DF, Kamal MM, El-Hefnawy MH and
El-Mesallamy HO: Serum vitamin D and its upregulated protein,
thioredoxin interacting protein, are associated with beta-cell
dysfunction in adult patients with type 1 and type 2 diabetes. Can
J Diabetes. 42:588–594. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Shroff G, Shroff R and Gupta R: Analysis
of the regulation pathways via microarray and miRNA studies: Human
embryonic stem cells to treat diabetes mellitus type-II. Am J Stem
Cells. 7:48–55. 2018.PubMed/NCBI
|
|
3
|
Sireesh D, Dhamodharan U, Ezhilarasi K,
Vijay V and Ramkumar KM: Association of NF-E2 related factor 2
(Nrf2) and inflammatory cytokines in recent onset type 2 diabetes
mellitus. Sci Rep. 8(5126)2018.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhou Z, Sun B, Li X and Zhu C: DNA
methylation landscapes in the pathogenesis of type 2 diabetes
mellitus. Nutr Metab (Lond). 15(47)2018.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Stumvoll M, Goldstein BJ and van Haeften
TW: Type 2 diabetes: Principles of pathogenesis and therapy.
Lancet. 365:1333–1346. 2005.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Ruan Y, Lin N, Ma Q, Chen R, Zhang Z, Wen
W, Chen H and Sun J: Circulating LncRNAs analysis in patients with
type 2 diabetes reveals novel genes influencing glucose metabolism
and islet β-cell function. Cell Physiol Biochem. 46:335–350.
2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Jin F, Wang N, Zhu Y, You L, Wang L, De W
and Tang W: Downregulation of long noncoding RNA Gas5 affects cell
cycle and insulin secretion in mouse pancreatic β cells. Cell
Physiol Biochem. 43:2062–2073. 2017.PubMed/NCBI View Article : Google Scholar
|
|
8
|
DeSouza SV, Singh RG, Yoon HD, Murphy R,
Plank LD and Petrov MS: Pancreas volume in health and disease: A
systematic review and meta-analysis. Expert Rev Gastroenterol
Hepatol. 12:757–766. 2018.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Butler AE, Janson J, Bonner-Weir S, Ritzel
R, Rizza RA and Butler PC: Beta-cell deficit and increased
beta-cell apoptosis in humans with type 2 diabetes. Diabetes.
52:102–110. 2003.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yin Y, Hao H, Cheng Y, Zang L, Liu J, Gao
J, Xue J, Xie Z, Zhang Q, Han W and Mu Y: Human umbilical
cord-derived mesenchymal stem cells direct macrophage polarization
to alleviate pancreatic islets dysfunction in type 2 diabetic mice.
Cell Death Dis. 9(760)2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Guo S, Dai C, Guo M, Taylor B, Harmon JS,
Sander M, Robertson RP, Powers AC and Stein R: Inactivation of
specific β cell transcription factors in type 2 diabetes. J Clin
Invest. 123:3305–3316. 2013.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Robertson RP, Harmon J, Tran PO, Tanaka Y
and Takahashi H: Glucose toxicity in beta-cells: Type 2 diabetes,
good radicals gone bad, and the glutathione connection. Diabetes.
52:581–587. 2003.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Okauchi S, Shimoda M, Obata A, Kimura T,
Hirukawa H, Kohara K, Mune T, Kaku K and Kaneto H: Protective
effects of SGLT2 inhibitor luseogliflozin on pancreatic β-cells in
obese type 2 diabetic db/db mice. Biochem Biophys Res Commun.
470:772–782. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zheng S, Zhao M, Ren Y, Wu Y and Yang J:
Sesamin suppresses STZ induced INS-1 cell apoptosis through
inhibition of NF-κB activation and regulation of Bcl-2 family
protein expression. Eur J Pharmacol. 750:52–58. 2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kahn SE, Cooper ME and Del Prato S:
Pathophysiology and treatment of type 2 diabetes: Perspectives on
the past, present, and future. Lancet. 383:1068–1083.
2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang T, Wu Z, Sun L, Li W, Liu G and Tang
Y: A computational systems pharmacology approach to investigate
molecular mechanisms of herbal formula Tian-Ma-Gou-Teng-Yin for
treatment of Alzheimer's disease. Front Pharmacol.
9(668)2018.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Li Y, Li Y, Lu W, Li H, Wang Y, Luo H, Wu
Y, Dong W, Bai G and Zhang Y: Integrated network pharmacology and
metabolomics analysis of the therapeutic effects of Zi Dian Fang on
immune thrombocytopenic purpura. Front Pharmacol.
9(597)2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Hopkins AL: Network pharmacology: The next
paradigm in drug discovery. Nat Chem Biol. 4:682–690.
2008.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Qian F, Guo J, Jiang Z and Shen B:
Translational bioinformatics for cholangiocarcinoma: Opportunities
and challenges. Int J Biol Sci. 14:920–929. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Zhou W, Gong L, Li X, Wan Y, Wang X, Li H
and Jiang B: Screening key candidate genes and pathways involved in
insulinoma by microarray analysis. Medicine (Baltimore).
97(e10826)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Marselli L, Thorne J, Dahiya S, Sgroi DC,
Sharma A, Bonner-Weir S, Marchetti P and Weir GC: Gene expression
profiles of Beta-cell enriched tissue obtained by laser capture
microdissection from subjects with type 2 diabetes. PLoS One.
5(e11499)2010.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Zhao Y, Zhang X, Zhao Y, Kong D, Qin F,
Sun J and Dong Y: Identification of potential therapeutic target
genes, key miRNAs and mechanisms in acute myeloid leukemia based on
bioinformatics analysis. Med Oncol. 32(152)2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zhou W, Yin M, Cui H, Wang N, Zhao LL,
Yuan LZ, Yang XP, Ding XM, Men FZ, Ma X and Na JR: Identification
of potential therapeutic target genes and mechanisms in
non-small-cell lung carcinoma in non-smoking women based on
bioinformatics analysis. Eur Rev Med Pharmacol Sci. 19:3375–3384.
2015.PubMed/NCBI
|
|
24
|
Szklarczyk D, Gable AL, Lyon D, Junge A,
Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork
P, et al: STRING v11: Protein-protein association networks with
increased coverage, supporting functional discovery in genome-wide
experimental datasets. Nucleic Acids Res. 47 (D1):D607–D613.
2019.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Saito R, Smoot ME, Ono K, Ruscheinski J,
Wang PL, Lotia S, Pico AR, Bader GD and Ideker T: A travel guide to
cytoscape plugins. Nat Methods. 9:1069–1076. 2012.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Xu X, Shi Z, Hu J, Yuan B, Huang H, Fang
H, Yin X, Nie N and Sheng X: Identification of differentially
expressed genes associated with burn sepsis using microarray. Int J
Mol Med. 36:1623–1629. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Zmuda EJ, Powell CA and Hai T: A method
for murine islet isolation and subcapsular kidney transplantation.
J Vis Exp. pii(2096)2011.PubMed/NCBI View
Article : Google Scholar
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Nasteska D and Hodson DJ: The role of beta
cell heterogeneity in islet function and insulin release. J Mol
Endocrinol. 61:R43–R60. 2018.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Unnikrishnan R, Pradeepa R, Joshi SR and
Mohan V: Type 2 diabetes: Demystifying the global epidemic.
Diabetes. 66:1432–1442. 2017.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Puff R, Dames P, Weise M, Göke B, Seissler
J, Parhofer KG and Lechner A: Reduced proliferation and a high
apoptotic frequency of pancreatic beta cells contribute to
genetically-determined diabetes susceptibility of db/db BKS mice.
Horm Metab Res. 43:306–311. 2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Li Y, Zheng J, Shen Y, Li W, Liu M, Wang
J, Zhu S and Wu M: Comparative study of liraglutide and insulin
glargine on glycemic control and pancreatic β-cell function in
db/db mice. Med Sci Monit. 24:3293–3300. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Ding L, Fan L, Xu X, Fu J and Xue Y:
Identification of core genes and pathways in type 2 diabetes
mellitus by bioinformatics analysis. Mol Med Rep. 20:2597–2608.
2019.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Zhong M, Wu Y, Ou W, Huang L and Yang L:
Identification of key genes involved in type 2 diabetic islet
dysfunction: A bioinformatics study. Biosci Rep. 39:
pii(BSR20182172)2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Jin SM, Hong YJ, Jee JH, Bae JC, Hur KY,
Lee MK and Kim JH: Change in serum albumin concentration is
inversely and independently associated with risk of incident
metabolic syndrome. Metabolism. 65:1629–1635. 2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Liu M, Tang J, Zeng J and He Y: Higher
serum albumin was related with diabetes incidence and the impact of
BMI changes: Based on cohort study of 18,384 Chinese male elderly.
J Diabetes Complications. 31:1663–1668. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Khoundabi B, Kazemnejad A, Mansourian M
and Faghihimani E: Factors associated with serum albumin in
diabetes mellitus type 2 with microalbuminuria using non-normal
mixed models: A prospective cohort study. Iran Red Crescent Med J.
18(e20671)2016.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Cimini FA, Barchetta I, Porzia A, Mainiero
F, Costantino C, Bertoccini L, Ceccarelli V, Morini S, Baroni MG,
Lenzi A and Cavallo MG: Circulating IL-8 levels are increased in
patients with type 2 diabetes and associated with worse
inflammatory and cardiometabolic profile. Acta Diabetol.
54:961–967. 2017.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Zozuliñska D, Majchrzak A, Sobieska M,
Wiktorowicz K and Wierusz-Wysocka B: Serum interleukin-8 level is
increased in diabetic patients. Diabetologia. 42:117–118.
1999.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Lin D, Chun TH and Kang L: Adipose
extracellular matrix remodelling in obesity and insulin resistance.
Biochem Pharmacol. 119:8–16. 2016.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Kobayashi N, Okazaki S, Sampetrean O, Irie
J, Itoh H and Saya H: CD44 variant inhibits insulin secretion in
pancreatic β cells by attenuating LAT1-mediated amino acid uptake.
Sci Rep. 8(2785)2018.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Kodama K, Horikoshi M, Toda K, Yamada S,
Hara K, Irie J, Sirota M, Morgan AA, Chen R, Ohtsu H, et al:
Expression-based genome-wide association study links the receptor
CD44 in adipose tissue with type 2 diabetes. Proc Natl Acad Sci
USA. 109:7049–7054. 2012.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Liu LF, Kodama K, Wei K, Tolentino LL,
Choi O, Engleman EG, Butte AJ and McLaughlin T: The receptor CD44
is associated with systemic insulin resistance and proinflammatory
macrophages in human adipose tissue. Diabetologia. 58:1579–1586.
2015.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Czemplik M, Kulma A, Wang YF and Szopa J:
Therapeutic strategies of plant-derived compounds for diabetes via
regulation of monocyte chemoattractant protein-1. Curr Med Chem.
24:1453–1468. 2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Haller H, Bertram A, Nadrowitz F and Menne
J: Monocyte chemoattractant protein-1 and the kidney. Curr Opin
Nephrol Hypertens. 25:42–49. 2016.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Chow FY, Nikolic-Paterson DJ, Ma FY, Ozols
E, Rollins BJ and Tesch GH: Monocyte chemoattractant
protein-1-induced tissue inflammation is critical for the
development of renal injury but not type 2 diabetes in obese db/db
mice. Diabetologia. 50:471–480. 2007.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Hopfgarten J, Stenwall PA, Wiberg A,
Anagandula M, Ingvast S, Rosenling T, Korsgren O and Skog O: Gene
expression analysis of human islets in a subject at onset of type 1
diabetes. Acta Diabetol. 51:199–204. 2014.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Dishi M, Hevner K, Qiu C, Fida NG, Abetew
DF, Williams MA and Enquobahrie DA: Early pregnancy maternal
hepatocyte growth factor and risk of gestational diabetes. Br J Med
Med Res. 9: pii(BJMMR.18632)2015.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Mesarosova L, Ochodnicky P, Leemans JC,
Florquin S, Krenek P and Klimas J: High glucose induces
HGF-independent activation of Met receptor in human renal tubular
epithelium. J Recept Signal Transduct Res. 37:535–542.
2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Konya H, Miuchi M, Satani K, Matsutani S,
Tsunoda T, Yano Y, Katsuno T, Hamaguchi T, Miyagawa J and Namba M:
Hepatocyte growth factor, a biomarker of macroangiopathy in
diabetes mellitus. World J Diabetes. 5:678–688. 2014.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Mellado-Gil J, Rosa TC, Demirci C,
Gonzalez-Pertusa JA, Velazquez-Garcia S, Ernst S, Valle S, Vasavada
RC, Stewart AF, Alonso LC and Garcia-Ocaña A: Disruption of
hepatocyte growth factor/c-Met signaling enhances pancreatic
beta-cell death and accelerates the onset of diabetes. Diabetes.
60:525–536. 2011.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Araújo TG, Oliveira AG, Carvalho BM,
Guadagnini D, Protzek AO, Carvalheira JB, Boschero AC and Saad MJ:
Hepatocyte growth factor plays a key role in insulin
resistance-associated compensatory mechanisms. Endocrinology.
153:5760–5769. 2012.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Hart NJ, Aramandla R, Poffenberger G,
Fayolle C, Thames AH, Bautista A, Spigelman AF, Babon JAB, DeNicola
ME, Dadi PK, et al: Cystic fibrosis-related diabetes is caused by
islet loss and inflammation. JCI Insight. 3:
pii(98240)2018.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Kayani K, Mohammed R and Mohiaddin H:
Cystic fibrosis-related diabetes. Front Endocrinol (Lausanne).
9(20)2018.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Rowntree RK and Harris A: The phenotypic
consequences of CFTR mutations. Ann Hum Genet. 67:471–485.
2003.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Marzluff WF, Gongidi P, Woods KR, Jin J
and Maltais LJ: The human and mouse replication-dependent histone
genes. Genomics. 80:487–498. 2002.PubMed/NCBI
|
|
57
|
Yan S, Jiang Z, Cheng L, Lin Y, Fan B, Luo
L, Yan Y, Yang L and Shen X: TLR4 knockout can improve dysfunction
of β-cell by rebalancing proteomics disorders in pancreas of obese
rats. Endocrine. 67:67–79. 2020.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Huang Q, Bu S, Yu Y, Guo Z, Ghatnekar G,
Bu M, Yang L, Lu B, Feng Z, Liu S and Wang F: Diazoxide prevents
diabetes through inhibiting pancreatic beta-cells from apoptosis
via Bcl-2/Bax rate and p38-beta mitogen-activated protein kinase.
Endocrinology. 148:81–91. 2007.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Thameem F, Voruganti VS, Blangero J,
Comuzzie AG and Abboud HE: Evaluation of neurotrophic tyrosine
receptor kinase 2 (NTRK2) as a positional candidate gene for
variation in estimated glomerular filtration rate (eGFR) in Mexican
American participants of San Antonio Family Heart study. J Biomed
Sci. 22(23)2015.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Yoshii A and Constantine-Paton M:
Postsynaptic BDNF-TrkB signaling in synapse maturation, plasticity,
and disease. Dev Neurobiol. 70:304–322. 2010.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Ribases M, Gratacos M, Badia A, Jimenez L,
Solano R, Vallejo J, Fernandez-Aranda F and Estivill X:
Contribution of NTRK2 to the genetic susceptibility to anorexia
nervosa, harm avoidance and minimum body mass index. Mol
Psychiatry. 10:851–860. 2005.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Gobato AO, Vasques AC, Zambon MP, Barros
Filho Ade A and Hessel G: Metabolic syndrome and insulin resistance
in obese adolescents. Rev Paul Pediatr. 32:55–62. 2014.PubMed/NCBI View Article : Google Scholar
|
